Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days to obtain the report for the NTRK1/2/3 Gene Rearrangement Test by FISH is typically 14 business days.

What are the prerequisites for the test NTRK1/2/3 Gene Rearrangement Test by FISH

  • Specimen Type: Formalin-fixed, paraffin-embedded (FFPE) tissue block or slides
  • Specimen Size: Minimum of 5 unstained slides or 1 FFPE tissue block
  • Specimen Requirements: Adequate tumor content for analysis
  • Turnaround Time: 7-10 days

What are the measure values for the test NTRK1/2/3 Gene Rearrangement Test by FISH

  • NTRK1 Gene Rearrangement Test: Positive or Negative
  • NTRK2 Gene Rearrangement Test: Positive or Negative
  • NTRK3 Gene Rearrangement Test: Positive or Negative

What does this test NTRK1/2/3 Gene Rearrangement Test by FISH identify?

  • This test identifies rearrangements involving the NTRK1, NTRK2, and NTRK3 genes.
  • Rearrangements in these genes can result in fusion proteins that drive the growth of certain types of cancer.
  • Fluorescence in situ hybridization (FISH) is used to detect these rearrangements by labeling specific DNA sequences with fluorescent probes.
  • Identifying NTRK gene rearrangements can help guide targeted therapy options for patients with cancers that harbor these alterations.

Why is this test NTRK1/2/3 Gene Rearrangement Test by FISH taken?

  • The NTRK1/2/3 Gene Rearrangement Test by FISH is taken to detect rearrangements involving the NTRK genes, which can lead to the formation of oncogenic fusion proteins.
  • These gene rearrangements are known to drive the growth of certain types of cancer, such as non-small cell lung cancer, colorectal cancer, and various types of sarcomas.
  • The test helps in identifying patients who may benefit from targeted therapy with NTRK inhibitors, such as larotrectinib or entrectinib.
  • It is also used to guide treatment decisions and monitor the response to targeted therapy in patients with NTRK gene rearrangements.
  • Overall, the NTRK1/2/3 Gene Rearrangement Test by FISH plays a crucial role in personalized medicine and improving outcomes for cancer patients with NTRK gene alterations.

No FAQs available.

Customer Google Rating